- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
已有87家主力机构披露2025-06-30报告期持股数据，持仓量总计3.16亿股，占流通A股54.08%
- 波段诊断：
-
技术面诊股
诊断结果：7.2技术面打败了89%的股票
技术面评分前10的股票
近期的平均成本为14.58元。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为14.58元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"14.58","date":1763626019,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，跑赢行业平均水平。
[{"date":"2025.11.21","stock":"-1.49","trade":"-3.30","ind":"-3.41"},{"date":"2025.11.20","stock":"0.00","trade":"0.07","ind":"-0.76"},{"date":"2025.11.19","stock":"-0.81","trade":"-1.77","ind":"-0.00"},{"date":"2025.11.18","stock":"-0.53","trade":"-1.55","ind":"-0.92"},{"date":"2025.11.17","stock":"-0.73","trade":"-1.44","ind":"-0.11"},{"date":"2025.11.14","stock":"1.14","trade":"1.17","ind":"-1.93"},{"date":"2025.11.13","stock":"-0.27","trade":"0.48","ind":"1.78"},{"date":"2025.11.12","stock":"-0.53","trade":"0.85","ind":"-0.36"},{"date":"2025.11.11","stock":"1.42","trade":"1.11","ind":"-1.03"},{"date":"2025.11.10","stock":"1.72","trade":"0.84","ind":"0.18"},{"date":"2025.11.07","stock":"0.97","trade":"0.89","ind":"-0.36"},{"date":"2025.11.06","stock":"-0.28","trade":"-0.37","ind":"1.73"},{"date":"2025.11.05","stock":"-0.28","trade":"0.46","ind":"0.37"},{"date":"2025.11.04","stock":"-0.14","trade":"-0.65","ind":"-1.71"},{"date":"2025.11.03","stock":"-0.48","trade":"0.77","ind":"0.19"},{"date":"2025.10.31","stock":"0.41","trade":"2.11","ind":"-1.14"},{"date":"2025.10.30","stock":"-0.34","trade":"-1.13","ind":"-1.16"},{"date":"2025.10.29","stock":"-1.15","trade":"-0.32","ind":"1.95"},{"date":"2025.10.28","stock":"-4.90","trade":"-0.54","ind":"-0.44"},{"date":"2025.10.27","stock":"-0.26","trade":"-0.12","ind":"1.51"},{"date":"2025.10.24","stock":"-0.26","trade":"-0.63","ind":"2.02"}]
葵花药业,深证成指,中药指数
压力支撑
该股压力位为14.58元，支撑位为14.36元。
[{"text":"\u538b\u529b\u4f4d","value":"14.58","date":1763654400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"14.36","date":1763654400,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.7资金面打败了43%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金流出较多，不建议投资者关注该行业的个股。
更新时间：11月21日 20:30
| 机构今日流向(万元) | -2537.08 | 机构5日流向(万元) | -13761.98 |
| 机构10日流向(万元) | -10739.68 | 机构20日流向(万元) | -14414.46 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1100.69万股，其中基金净减仓7家，主力净减仓55家，请投资者中长期谨慎为宜。
截止2025-06-30，共87家主力机构（基金84家，一般法人3家），持仓量总计31583.21万股，占流通A股54.08%
其中，基金持仓与2024-12-31相比：
增仓：21家 ，增持 139.11万股
减仓：28家 ，减持 184.44万股
新出现在主力名单中：28家 ，持有239.74万股
从主力名单中消失：83家 ，原持有1255.65万股
其中，基金持仓与2024-12-31相比：
增仓：21家 ，增持 139.11万股
减仓：28家 ，减持 184.44万股
新出现在主力名单中：28家 ，持有239.74万股
从主力名单中消失：83家 ，原持有1255.65万股
消息面诊股
诊断结果：4.7消息面打败了0%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 葵花药业：11月20日获融资买入357.27万元
2025-11-21 - 葵花酒业问东方酒：药交会跨界爆款的健康突围之路
2025-11-20 - 葵花药业：11月19日获融资买入331.03万元
2025-11-20 - 葵花药业：11月18日获融资买入173.36万元
2025-11-19 - 葵花药业：公司产品覆盖“儿童用药、消化系统、呼吸感
2025-11-18 - 葵花药业：11月17日获融资买入454.26万元
2025-11-18 - 葵花药业：公司产品覆盖全国
2025-11-18 - 葵花药业：公司拥有成人呼吸抗感用药感冒灵胶囊/颗粒
2025-11-18 - “聚乙二醇3350系列产品研发及产业化项目”荣获迁
2025-11-17 - 唐山葵花复方聚乙二醇电解质散成功获批
2025-11-17
消息列表
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-11-01 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-10-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-10-27 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-10-11 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-11 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-08-20 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-07-26 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-07-12 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-07-09 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 高管变动 | 因退休原因 | 2025-06-24 |
| 利好 | 分红转增 | 10派5元(含税) | 2025-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-25 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-01-18 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-01-08 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 3条 | 0条 | 3条 |
| 利空 | 4条 | 2条 | 2条 |
行业面诊股
诊断结果：2.9行业面打败了47%的股票
中药行业最新资金流向
近10日来该行业走势不明显，接近大盘。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.11.21","price":"-3.41","value":"-3.30"},{"date":"2025.11.20","price":"-0.76","value":"0.07"},{"date":"2025.11.19","price":"-0.00","value":"-1.77"},{"date":"2025.11.18","price":"-0.92","value":"-1.55"},{"date":"2025.11.17","price":"-0.11","value":"-1.44"},{"date":"2025.11.14","price":"-1.93","value":"1.17"},{"date":"2025.11.13","price":"1.78","value":"0.48"},{"date":"2025.11.12","price":"-0.36","value":"0.85"},{"date":"2025.11.11","price":"-1.03","value":"1.11"},{"date":"2025.11.10","price":"0.18","value":"0.84"},{"date":"2025.11.07","price":"-0.36","value":"0.89"},{"date":"2025.11.06","price":"1.73","value":"-0.37"},{"date":"2025.11.05","price":"0.37","value":"0.46"},{"date":"2025.11.04","price":"-1.71","value":"-0.65"},{"date":"2025.11.03","price":"0.19","value":"0.77"},{"date":"2025.10.31","price":"-1.14","value":"2.11"},{"date":"2025.10.30","price":"-1.16","value":"-1.13"},{"date":"2025.10.29","price":"1.95","value":"-0.32"},{"date":"2025.10.28","price":"-0.44","value":"-0.54"},{"date":"2025.10.27","price":"1.51","value":"-0.12"},{"date":"2025.10.24","price":"2.02","value":"-0.63"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 众生药业 | 30.35% | -9.96% | 6.0分 |
| 2 | 维康药业 | 21.99% | 1.66% | 6.0分 |
| 3 | 金花股份 | 10.19% | -3.25% | 5.9分 |
| 4 | 太龙药业 | 9.62% | -7.95% | 5.8分 |
| 5 | 特一药业 | 8.94% | -22.29% | 5.9分 |
| 6 | 以岭药业 | 5.67% | -14.16% | 5.6分 |
| 8 | 济川药业 | 5.26% | -6.31% | 6.0分 |
| 10 | 精华制药 | 2.67% | -7.00% | 5.8分 |
| 12 | 华神科技 | 2.27% | -10.40% | 5.4分 |
| 14 | ST葫芦娃 | 1.66% | -7.27% | 4.5分 |
| 16 | 白云山 | 1.01% | -4.50% | 5.8分 |
| 18 | 上海凯宝 | 0.00% | -6.94% | 5.1分 |
| 20 | 康缘药业 | -0.47% | -9.46% | 5.5分 |
| 22 | 同仁堂 | -0.80% | -4.70% | 5.3分 |
| 24 | 寿仙谷 | -2.49% | -5.49% | 5.4分 |
| 26 | 桂林三金 | -2.93% | -5.52% | 6.5分 |
| 28 | 华润三九 | -3.04% | -4.67% | 5.8分 |
| 30 | 粤万年青 | -3.06% | -10.42% | 5.3分 |
| 32 | 新天药业 | -3.53% | -9.98% | 5.3分 |
| 34 | 益盛药业 | -3.58% | -9.49% | 5.1分 |
| 36 | 贵州三力 | -3.90% | -8.22% | 5.5分 |
| 38 | 羚锐制药 | -4.07% | -2.38% | 5.9分 |
| 40 | 九芝堂 | -4.38% | -11.34% | 5.4分 |
| 42 | 信邦制药 | -4.70% | -8.29% | 5.6分 |
| 44 | 红日药业 | -5.03% | -9.11% | 5.3分 |
| 46 | - | -5.18% | -10.10% | 分 |
| 48 | 益佰制药 | -5.37% | -10.60% | 5.4分 |
| 50 | 步长制药 | -5.64% | -8.62% | 5.8分 |
| 52 | 中恒集团 | -6.07% | -10.24% | 5.2分 |
| 54 | 葵花药业 | -6.49% | -3.51% | 4.9分 |
| 56 | ST香雪 | -7.51% | -8.88% | 4.2分 |
| 58 | 奇正藏药 | -7.60% | -7.00% | 5.8分 |
| 60 | 吉林敖东 | -7.98% | -9.56% | 4.9分 |
| 62 | 启迪药业 | -8.91% | -8.39% | 4.7分 |
| 64 | 恩威医药 | -10.03% | -13.28% | 5.4分 |
| 66 | 天目药业 | -13.85% | -12.35% | 5.5分 |
| 68 | 万邦德 | -14.58% | -13.06% | 5.3分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 57/109 ， 52/109。
[{"date":"2025-09-30","value":"-0.80","vol":"4.74"},{"date":"2025-06-30","value":"1.84","vol":"3.98"},{"date":"2025-03-31","value":"1.30","vol":"2.21"},{"date":"2024-12-31","value":"10.76","vol":"4.80"},{"date":"2024-09-30","value":"12.70","vol":"2.91"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.80 | 1.84 | 1.30 | 10.76 | 12.70 |
| 行业(%) | 4.74 | 3.98 | 2.21 | 4.80 | 2.91 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"37.65","vol":"52.31"},{"date":"2025-06-30","value":"38.85","vol":"52.86"},{"date":"2025-03-31","value":"37.29","vol":"53.38"},{"date":"2024-12-31","value":"44.89","vol":"52.74"},{"date":"2024-09-30","value":"52.23","vol":"53.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
37.65 | 38.85 | 37.29 | 44.89 | 52.23 |
| 行业(%) | 52.31 | 52.86 | 53.38 | 52.74 | 53.11 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 65/109 ， 62/109。
[{"date":"2025-09-30","value":"-43.24","vol":"-7.31"},{"date":"2025-06-30","value":"-48.17","vol":"-7.31"},{"date":"2025-03-31","value":"-56.30","vol":"-7.18"},{"date":"2024-12-31","value":"-40.76","vol":"-7.35"},{"date":"2024-09-30","value":"-29.95","vol":"-5.11"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-43.24 | -48.17 | -56.30 | -40.76 | -29.95 |
| 行业(%) | -7.31 | -7.31 | -7.18 | -7.35 | -5.11 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"-105.72","vol":"-2.54"},{"date":"2025-06-30","value":"-83.28","vol":"2.98"},{"date":"2025-03-31","value":"-77.62","vol":"-37.19"},{"date":"2024-12-31","value":"-56.03","vol":"-146.29"},{"date":"2024-09-30","value":"-31.06","vol":"61.78"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-105.72 | -83.28 | -77.62 | -56.03 | -31.06 |
| 行业(%) | -2.54 | 2.98 | -37.19 | -146.29 | 61.78 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/109 ， 39/109。
[{"date":"2025-09-30","value":"0.31","vol":"0.35"},{"date":"2025-06-30","value":"0.23","vol":"0.24"},{"date":"2025-03-31","value":"0.11","vol":"0.12"},{"date":"2024-12-31","value":"0.53","vol":"0.50"},{"date":"2024-09-30","value":"0.46","vol":"0.37"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.31 | 0.23 | 0.11 | 0.53 | 0.46 |
| 行业(次) | 0.35 | 0.24 | 0.12 | 0.50 | 0.37 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.36","vol":"1.73"},{"date":"2025-06-30","value":"0.99","vol":"1.18"},{"date":"2025-03-31","value":"0.50","vol":"0.61"},{"date":"2024-12-31","value":"2.14","vol":"2.42"},{"date":"2024-09-30","value":"1.57","vol":"1.81"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.36 | 0.99 | 0.50 | 2.14 | 1.57 |
| 行业(次) | 1.73 | 1.18 | 0.61 | 2.42 | 1.81 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"-34.59","vol":"9.48"},{"date":"2025-06-30","value":"38.34","vol":"20.05"},{"date":"2025-03-31","value":"15.33","vol":"-0.23"},{"date":"2024-12-31","value":"22.36","vol":"15.64"},{"date":"2024-09-30","value":"-58.50","vol":"5.86"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -34.59 | 38.34 | 15.33 | 22.36 | -58.50 |
| 行业 | 9.48 | 20.05 | -0.23 | 15.64 | 5.86 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.24","vol":"1.02"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.50","vol":"1.45"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.24 | - | 0.50 | - |
| 行业 | 0.00 | 1.02 | 0.00 | 1.45 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 57/109 ， 58/109。
[{"date":"2025-09-30","value":"4.53","vol":"3.05"},{"date":"2025-06-30","value":"4.44","vol":"2.90"},{"date":"2025-03-31","value":"4.15","vol":"2.99"},{"date":"2024-12-31","value":"3.78","vol":"2.88"},{"date":"2024-09-30","value":"4.00","vol":"3.25"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
4.53 | 4.44 | 4.15 | 3.78 | 4.00 |
| 行业 | 3.05 | 2.90 | 2.99 | 2.88 | 3.25 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"3.43","vol":"2.21"},{"date":"2025-06-30","value":"3.45","vol":"2.13"},{"date":"2025-03-31","value":"3.18","vol":"2.22"},{"date":"2024-12-31","value":"2.82","vol":"2.11"},{"date":"2024-09-30","value":"2.89","vol":"2.43"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
3.43 | 3.45 | 3.18 | 2.82 | 2.89 |
| 行业 | 2.21 | 2.13 | 2.22 | 2.11 | 2.43 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 53/109 ， 53/109。
[{"date":"2025-09-30","value":"17.40","vol":"33.12"},{"date":"2025-06-30","value":"18.32","vol":"33.87"},{"date":"2025-03-31","value":"19.49","vol":"33.29"},{"date":"2024-12-31","value":"21.21","vol":"34.05"},{"date":"2024-09-30","value":"20.79","vol":"32.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
17.40 | 18.32 | 19.49 | 21.21 | 20.79 |
| 行业(%) | 33.12 | 33.87 | 33.29 | 34.05 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.22","vol":"0.75"},{"date":"2025-06-30","value":"0.23","vol":"0.74"},{"date":"2025-03-31","value":"0.25","vol":"0.72"},{"date":"2024-12-31","value":"0.28","vol":"0.75"},{"date":"2024-09-30","value":"0.28","vol":"3.20"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.22 | 0.23 | 0.25 | 0.28 | 0.28 |
| 行业(%) | 0.75 | 0.74 | 0.72 | 0.75 | 3.20 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"7.05","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"8.67","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"11.19","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"4.92","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]